Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 5

Romatizmal mitral kapak hastalarında nötrofilin lenfosite oranı artmıştır

Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis?

Pages
380–384
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased NLR can also be a sign of ongoing chronic inflammation in patients with RMVS

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The role of systemic and chronic inflammatory processes in the pathophysiology of rheumatic heart valve disease is well known.
📊
Key Findings & Data:Among patients who underwent transthoracic echocardiography between January 2008-March 2013, 314 patients with RMVS were included retrospectively in the study.
💡
Conclusion & Impact:Increased NLR can also be a sign of ongoing chronic inflammation in patients with RMVS
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The role of systemic and chronic inflammatory processes in the pathophysiology of rheumatic heart valve disease is well known. The neutrophil-to-lymphocyte ratio (NLR) was shown to be an indicator of systemic inflammation. In this study, we aimed to investigate relationship between NLR as a marker of systemic inflammation and rheumatic mitral valve stenosis (RMVS).Methods: This is a retrospective study. Among patients who underwent transthoracic echocardiography between January 2008-March 2013, 314 patients with RMVS were included retrospectively in the study. The control group included 57 healthy persons who underwent transthoracic echocardiography during the study period. Basal characteristics and NLR were compared between the two groups. Independent predictors of RMVS were determined by logistic regression analysis.Results: Basal characteristics were similar among the groups (age, 50.2±14.2 vs. 49.2±13.0, p=0.60). The NLR was significantly higher in patients with RMVS [2.9 (0.6-13.0) vs. 2.1 (0.7-5.8), p<0.001]. Besides, C-reactive protein (CRP) was also higher in the RMVS group [5.99 (0.3-23.7) vs. 2.98 (0.6-6.3), p=0.001]. In the regression analysis, NLR (OR: 2.24, p=0.04), CRP (OR: 1.34, p=0.03), and left atrial diameter (OR: 1.21, p=0.001) were independent predictors of RMVS. In the correlation analysis, there was a significant positive correlation between NLR and CRP (r=0.43, p<0.001).Conclusion: We found that NLR was significantly increased in RMVS. Furthermore, NLR was an independent predictor of the presence of RMVS in our study population. According to these findings, NLR can be used as a predictor of RMVS. Since it is an easily available and cheap method, it can easily be used in daily clinical practice. Increased NLR can also be a sign of ongoing chronic inflammation in patients with RMVS

Özet

Amaç: Romatizmal kalp kapak hastalığının patofizyolojisinde sistemik ve kronik enflamatuvar sürecin rolü iyi bilinmektedir. Nötrofilin lenfosite oranının (NLO) sistemik enflamasyonun bir göstergesi olduğu gösterilmiştir. Biz bu çalışmamızda enflamasyon belirteci olan NLO ile romatizmal mitral kapak hastalığı (RMKH) arasındaki ilişkiyi incelemeyi amaçladık. Yöntemler: Ocak 2008-Mart 2013 tarihleri arasında transtorasik ekokardiyografi yapılan hastalar arasından RMKH olan 314 hasta retrospektif olarak çalışmaya dahil edildi. Kontrol grubu, çalışma döneminde transtorasik ekokardiyografi yapılan 57 sağlıklı bireyi içermektedir. Temel özellikler ve NLO iki grup arasında karşılaştırıldı. RMKH'nın bağımsız öngördürücüleri lojistik regresyon analizi ile tespit edildi. Bulgular: Temel özellikler gruplar arasında benzerdi. NLO, RMKH olan hastalarda anlamlı olarak daha yüksekti [2,9 (0,6-13,0)'e karşı 2,1 (0,7-5,8), p<0,001]. Ayrıca, C-reaktif protein (CRP) de RMKH grubunda daha yüksekti [5,99 (0,3-23,7)'e karşı 2,98 (0,6-6,3), p=0,001]. Regresyon analizinde, NLO (OR: 2,24, p=0,04), CRP (OR: 1,34, p=0,03) ve sol atriyal boyut (OR: 1,21, p=0,001) RMKH'nın bağımsız öngördürücüleriydi. Korelasyon analizinde NLO ile CRP arasında anlamlı pozitif korelasyon vardı (r=0,43, p<0,001). Sonuç: NLO'yu RMKH'de anlamlı şekilde artmış bulduk. Üstelik NLO bizim çalışma popülasyonumuzda RMKH varlığının bağımsız bir öngördürücüsü idi. Bu bulgulara göre NLO, RMKH'nın bir öngördürücüsü olarak kullanılabilir. Ucuz ve kolayca ulaşılabilen bir yöntem olduğundan günlük klinik uygulamada kolayca kullanılabilir. Ayrıca artmış NLO, RMKH hastalarında devam eden kronik inflamasyonun bir işareti olabilir.

🔖

Cite This Article

AKBOĞA, M. K., AKYEL, A., ŞAHİNARSLAN, A., YAYLA, Ç., ALSANCAK, Y., GÖKALP, G., NURKOÇ, S., ABACI, A. (2015). Romatizmal mitral kapak hastalarında nötrofilin lenfosite oranı artmıştır. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 5, 380–384. https://ajindex.com/articles/365890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Filgner CR, Reichenbach DD, Otto CM. Pathology and etiology of valvular heart disease. In: Otto CM, editor. Valvular Heart Disease. 2nd ed. Philadelphia: WB Saunders; 2004.p.30-3
  2. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country: Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med 1994; 120: 177-83. [CrossRef] 3. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19: 1218-22. [CrossRef] 4. Gölbaşı Z, Uçar O, Keleş T, Şahin A, Cağlı K, Çamsarı A, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 2002; 4: 593-5. [CrossRef] 5. Yetkin E, Erbay AR, İleri M, Turhan H, Balcı M, Çehreli S, et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 2001; 88: 1209-11. [CrossRef] 6. Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003; 89: 1200-4. [CrossRef] 7. Kaya MG, Akpek M, Elçik D, Kalay N, Yarlioğlues M, Koç F, et al. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Am J Cardiol 2012; 109: 851-5. [CrossRef] 8. Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005; 15: 266-71. [CrossRef] 9. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165: 500-8. [CrossRef] 10. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43. [CrossRef] 11. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010; 105: 186-9